Pneuma Systems Corporation


Pneuma Systems Corporation specializes in designing and licensing closed-loop fluid control systems that precisely manage small fluid volumes without the complexity of traditional pumping mechanisms. The company leverages over 30 inventions and three novel subsystems to revolutionize fluid flow, workflow, information flow, and cash flow, aiming to transform the standard of care in infusion therapy. Pneuma is a small team of experienced medical device professionals working on a new technology platform for precise fluid delivery, with an emphasis on infusion therapy. Armed with a strong IP portfolio, Pneuma’s infusion controller is designed to support all venues of infusion therapy including acute care, standalone infusion centers, and home care. The design offers significant advances in fluid flow, information flow, and work flow. The design has been accepted into an accelerated review program by the U.S. Food and Drug Administration (FDA), known as STeP.

Pneuma Systems Corporation

Pneuma Systems Corporation

Pneuma Systems Corporation is currently seeking investment

Pneuma Systems Corporation is seeking a series-b investment in the range of 1m-5m

All Investment-seeking Members

What We Do

A novel infusion system that offers simplicity, precision, and safety, accepted into the FDA's Safer Technologies Program (STeP).

Pneuma Systems designs closed-loop control systems for precise fluid movement, essential in laboratory and clinical sciences.

Pneuma offers integrated solutions for intravenous fluid delivery, focusing on patient safety, reliability, and cost efficiency.


Routes of Administration

FDA Regulated Medical Devices


Key People


News & Updates

ECRI's list identifies potential sources of danger in health technology, with a focus on infusion pumps, and offers recommendations for reducing risks.

The 9th Edition calls for standardizing pump types within organizations to promote user familiarity and minimize re-establishing infusions after patient transfers.

Pneuma Systems Corporation's infusion system has been added to the FDA's Safer Technologies Program (STeP), which accelerates regulatory review for medical devices offering significant advantages over current options.